Jatenzo Cost in Maine 2026: Cash Price, Insurance, Medicaid and Savings Options

What Does Jatenzo Cost in Maine Right Now?

The list price Tolmar Pharmaceuticals charges for Jatenzo is roughly $900 per month, and Maine retail pharmacy data for 2026 confirms that cash-pay patients fill it at that same level. No meaningful regional discount applies at the pharmacy counter without a coupon or savings program. Patients without insurance coverage face that full amount every 30 days.

That figure reflects two capsules per day, taken with food, at the most common starting dose of 237 mg twice daily. The FDA-approved prescribing information for Jatenzo lists dose titration steps (158 mg, 237 mg, and 316 mg twice daily), so a patient titrated upward will pay the same monthly cash price because the capsule count stays fixed at 60 per month regardless of dose strength. [1]

The Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy states that clinicians should "prescribe testosterone therapy only to men with classic androgen deficiency syndromes" and document two morning serum total testosterone measurements below the normal range before initiating treatment. [2] That diagnostic gatekeeping matters for cost because insurers in Maine use those exact criteria when evaluating prior authorization requests.

Swerdloff et al. (J Clin Endocrinol Metab 2020, N=166 hypogonadal men) demonstrated that 87% of subjects achieved an average total testosterone concentration within the normal range (300 to 1 to 000 ng/dL) over the 24-hour PK profile at 90 days, supporting the once-approved, twice-daily oral dosing schedule that drives the monthly capsule count. [3]

Does Maine Medicaid Cover Jatenzo?

Maine Medicaid (MaineCare) covers Jatenzo for male hypogonadism, but prior authorization is required. Without PA approval, the pharmacy will reject the claim and the patient pays cash.

MaineCare's preferred drug list places testosterone products in a tier that requires documented clinical criteria before coverage activates. [4] To obtain PA, the prescribing clinician generally must submit: (1) a diagnosis of primary or secondary hypogonadism (ICD-10 E29.1 or E23.0), (2) two fasting morning serum total testosterone results below 300 ng/dL drawn at least one week apart, and (3) a clinical note explaining why an alternate formulation is not appropriate if a lower-cost product exists on the preferred list.

Maine's PA process runs through the Gainwell Technologies portal, and approval turnarounds for testosterone products typically run 2 to 5 business days for standard reviews and 24 hours for expedited clinical reviews when a prescriber certifies urgency. [5]

Once approved, the MaineCare cost-share for most enrollees is minimal, often $1 to $4 per fill depending on eligibility category. That makes successful PA approval the single highest-value step a Maine Medicaid patient can take to reduce Jatenzo cost.

If PA is denied initially, Maine law (22 M.R.S. § 2685) gives patients the right to a timely internal appeal and then an independent external review. [6] Clinicians who document the clinical rationale carefully on the first submission statistically face fewer denials, since most rejections cite missing lab documentation rather than a categorical exclusion of the drug.

Which Commercial Insurance Plans Cover Jatenzo in Maine?

Coverage varies significantly across the commercial plans sold in Maine, and no single answer applies to all carriers. The dominant commercial carriers in Maine include Anthem Blue Cross Blue Shield of Maine, Harvard Pilgrim Health Care, and Aetna, each of which maintains its own formulary tier placement for Jatenzo. [7]

Anthem BCBS Maine places testosterone products on specialty or non-preferred tiers in most plan designs, which means cost-share can range from $60 to over $200 per month after deductible, depending on the specific benefit design. Harvard Pilgrim and Aetna follow similar structures. In all cases, PA criteria closely mirror those of MaineCare: two low testosterone labs, confirmed diagnosis, and a step-edit requiring trial of a lower-cost formulation in some plans.

Patients covered under employer-sponsored plans governed by ERISA may find plan documents online through their HR portal or by requesting a Summary of Benefits and Coverage (SBC), which must disclose formulary tier and cost-share under 45 CFR 147.200. [8]

The fastest way to check Jatenzo-specific coverage before the prescription is written is to call the pharmacy benefits number on the back of the insurance card and ask specifically: "Is NDC 70377-002-01 (Jatenzo 237 mg) covered on my formulary, what tier, and is PA required?" Getting a specific NDC-level answer eliminates ambiguity.

Is Compounded Oral Testosterone Undecanoate Legal in Maine?

Yes. Licensed 503A compounding pharmacies operating in Maine may prepare oral testosterone undecanoate for individual patients with a valid prescription. [9] The FDA classifies testosterone as a bulk substance that 503A pharmacies may compound under federal law (21 U.S.C. § 503A), provided the compounding is done pursuant to a patient-specific prescription from a licensed practitioner. [10]

Maine's pharmacy practice law (32 M.R.S. § 13751 et seq.) does not impose additional restrictions beyond federal 503A requirements for this compound. Pharmacies must hold an active Maine Board of Pharmacy permit, and out-of-state compounders shipping into Maine must be registered with the Maine Board of Pharmacy as non-resident pharmacies. [11]

The cost difference is substantial. Compounded oral testosterone undecanoate from a 503A pharmacy commonly ranges from $0 (when covered as a compounded preparation by some insurance plans or through manufacturer assistance programs) to $60 to $120 per month cash-pay, compared with the $900 monthly cash price for brand-name Jatenzo. That gap exists because compounding pharmacies source bulk pharmaceutical-grade testosterone undecanoate directly, bypassing brand-name markup.

One important clinical caveat: compounded formulations have not undergone the same PK characterization as FDA-approved Jatenzo. The FDA's approved label for Jatenzo specifies that the lipidic capsule formulation is designed for lymphatic absorption, which reduces the first-pass metabolism that historically made oral testosterone ineffective. [1] A compounded capsule using a different excipient system may not replicate that absorption profile, so prescribers and patients should discuss bioavailability expectations before switching.

Can You Get a Jatenzo Prescription via Telehealth in Maine?

Telehealth prescribing of Jatenzo is legal in Maine. [12] Maine's telehealth law (22 M.R.S. § 3173-E) allows licensed physicians, nurse practitioners, and physician assistants to prescribe controlled substances via synchronous audio-video encounters when a valid patient-provider relationship has been established and the prescribing meets all applicable DEA and state requirements.

Testosterone is a Schedule III controlled substance under federal law (21 U.S.C. § 812), and Maine mirrors that scheduling. DEA rules require that a prescriber conducting a telehealth visit for a Schedule III substance either (a) conduct a prior in-person evaluation or (b) operate under a DEA-registered telemedicine platform that complies with the Ryan Haight Act and any subsequent special registration frameworks. [13]

Practically speaking, most HealthRX-affiliated providers in Maine conduct an initial synchronous video visit, review uploaded lab results (two morning testosterone draws), and can issue a Jatenzo prescription electronically to any licensed Maine pharmacy or to a 503A compounding pharmacy that ships to Maine. Lab work can be ordered through national lab networks (Quest, LabCorp) with Maine draw sites, so the entire intake process is achievable without an in-person clinic visit for most patients.

How Does the Tolmar Savings Card Work for Maine Patients?

Tolmar Pharmaceuticals offers a manufacturer copay savings program for commercially insured patients who are prescribed Jatenzo. Maine patients with eligible commercial insurance (not Medicaid, not Medicare, not any other government-funded plan) may enroll through the Tolmar patient support line or the Jatenzo manufacturer website.

The savings card caps the out-of-pocket cost for eligible commercially insured patients, with the specific cap amount subject to change by the manufacturer each calendar year. In prior program years the card reduced cost-share to as low as $0 per month for qualifying patients. [14] Maine patients should verify the current program terms directly with Tolmar at enrollment because benefit caps and eligibility rules are updated annually.

Key eligibility limitations: The program explicitly excludes patients whose primary coverage is any federal or state government plan, including MaineCare, Medicare Part D, TRICARE, and the VA. Patients with employer-sponsored plans or marketplace (ACA exchange) plans are generally eligible provided the plan itself covers Jatenzo, even at a non-preferred tier.

Enrollment takes roughly five minutes by phone. The prescriber's NPI number, patient date of birth, and insurance information are the required inputs. Cards are typically activated same-day.

What Is the Cheapest Way to Get Jatenzo in Maine?

The answer depends on insurance status. Four tiers of cost exist for Maine patients in 2026.

Tier 1, lowest cost. MaineCare-enrolled patients who obtain prior authorization pay essentially nothing ($1 to $4 per fill). Getting that PA approved is the priority.

Tier 2. Commercially insured patients who activate the Tolmar savings card may pay $0 to around $60 per month depending on current program terms and their plan's formulary placement.

Tier 3. Commercially insured patients without the savings card or with a plan that does not cover Jatenzo may find compounded oral testosterone undecanoate from a licensed Maine 503A pharmacy at $60 to $120 per month a practical alternative, after discussing the bioavailability difference with their prescriber.

Tier 4, highest cost. Uninsured or underinsured patients paying cash for brand Jatenzo face the full $900 monthly price. These patients should first check GoodRx and similar discount platforms, though significant discounts on brand specialty products are uncommon, and should seriously evaluate the 503A compounded route.

The framework above is intended for general guidance. Individual plan design, prior authorization outcomes, and compounding pharmacy availability all affect the final number a specific Maine patient pays.

What Lab Work Is Required Before Prescribing Jatenzo in Maine?

Two fasting morning serum total testosterone measurements are the standard pre-treatment requirement. Both the Endocrine Society guideline [2] and the FDA-approved Jatenzo labeling [1] specify that the diagnosis of hypogonadism requires clinical symptoms plus biochemical confirmation on at least two separate occasions before initiating therapy.

In Maine, the same two-draw requirement is used by MaineCare and most commercial insurers as the PA criterion. Labs should be drawn before 10 a.m. after an overnight fast, since testosterone concentrations follow a circadian rhythm and peak in the early morning. A value of <300 ng/dL on two separate morning draws, combined with signs or symptoms of androgen deficiency (low libido, fatigue, reduced muscle mass, mood changes), meets the diagnostic threshold used in the Swerdloff et al. key trial. [3]

Additional baseline labs typically ordered before TRT initiation include hematocrit (to establish a pre-treatment baseline given testosterone's erythropoietic effect), PSA in men over 40, and a lipid panel, since the Jatenzo FDA label carries a blood pressure monitoring requirement due to observed increases in diastolic blood pressure during the registration trial. [1] Specifically, the label notes that Jatenzo caused a mean increase of 3.5 mmHg in diastolic blood pressure, leading to the requirement that blood pressure be monitored at each visit during the first year of therapy. [1]

Monitoring Requirements and Follow-Up Costs in Maine

After starting Jatenzo, follow-up lab monitoring adds to the total annual cost. The Endocrine Society guideline recommends checking total testosterone 3 to 6 months after initiation, with the blood draw timed to capture the average concentration across the dosing interval rather than a peak or trough. [2] For Jatenzo specifically, a steady-state PK draw is ideally collected 4 to 6 hours post-dose based on the absorption profile described in the Swerdloff et al. study. [3]

Hematocrit should be rechecked at 3 to 6 months. If hematocrit exceeds 54%, the FDA label recommends withholding therapy until it falls below that threshold. [1] PSA monitoring frequency for men on TRT follows American Urological Association guidance. [15]

Telehealth follow-up visits in Maine are billed under standard evaluation and management codes. MaineCare reimburses telehealth E&M at parity with in-person visits under Maine's telehealth parity law (22 M.R.S. § 3173-H). [12] Commercial insurers in Maine are subject to parity requirements under P.L. 2019 c. 612, which extended telehealth coverage parity to all fully-insured commercial plans in the state.

How Jatenzo Compares to Other Testosterone Formulations on Cost in Maine

Jatenzo is the only FDA-approved oral testosterone product in the United States as of 2026. Alternatives available in Maine include topical gels (AndroGel, Testim, Vogelxo), transdermal patches (Androderm), injectable cypionate or enanthate (generic available), subcutaneous pellets (Testopel), and intranasal gel (Natesto).

Generic testosterone cypionate injection is by far the lowest-cost FDA-approved option, with a 10 mL multi-dose vial (200 mg/mL) available at Maine pharmacies for $30 to $80 cash-pay, covering 10 to 20 weeks of therapy at common doses. [16] The trade-off is injection frequency, potential injection-site discomfort, and the non-oral route.

Topical gels run $200 to $500 per month cash-pay for brand products, with generic testosterone gel available for $60 to $120 per month at many Maine pharmacies. [17]

Jatenzo's oral convenience, avoiding skin-transfer risk and needle aversion, justifies the higher price point for some patients. The Endocrine Society's guideline does not rank formulations by preference but advises shared decision-making that accounts for patient preferences, cost, and monitoring requirements. [2]

Blood Pressure Risk: A Maine-Specific Clinical Note

The Jatenzo FDA label requires blood pressure monitoring because the drug's registration trial observed a clinically relevant diastolic blood pressure increase. In Maine, where hypertension prevalence among adults is approximately 33% according to CDC Behavioral Risk Factor Surveillance System data, this monitoring requirement is practically significant. [18]

Prescribers in Maine should document baseline blood pressure at the initiating visit and recheck at every follow-up during the first 12 months. Patients with pre-existing uncontrolled hypertension (systolic >160 mmHg or diastolic >100 mmHg) should have blood pressure controlled before Jatenzo initiation per the label. [1]

The American Heart Association's 2017 hypertension guideline defines hypertension stage 2 as systolic ≥140 or diastolic ≥90 mmHg, providing the benchmark clinicians use when deciding whether a patient is a safe Jatenzo candidate. [19]

Jatenzo Dose Titration and Its Effect on Cost

Jatenzo starts at 237 mg twice daily. After 90 days, total testosterone levels guide titration: if average testosterone is below 300 ng/dL, increase to 316 mg twice daily; if above 1 to 050 ng/dL, decrease to 158 mg twice daily. [1]

Because Jatenzo is sold in 158 mg, 237 mg, and 316 mg capsule strengths and all strengths are dispensed at 60 capsules per 30-day supply, the monthly cash price of approximately $900 does not change with titration. Insurance formularies also typically apply the same tier and cost-share to all three strengths. This is clinically convenient but financially neutral, confirming that dose titration does not provide a route to cost reduction for brand Jatenzo.

Compounded oral testosterone undecanoate, by contrast, can be prepared at custom strengths. A compounding pharmacy may prepare a formulation at the exact dose a patient needs, and pricing is generally per-capsule at the pharmacy's compounding rate rather than a fixed brand price. [9]

Navigating Prior Authorization in Maine: Practical Steps

Getting prior authorization approved on the first submission saves time and avoids gaps in therapy. The following sequence reflects best practice for Maine prescribers:

Collect two fasting morning testosterone labs at least one week apart, both before 10 a.m., both below 300 ng/dL. Document clinical symptoms in the chart note using the Androgen Deficiency in Aging Males (ADAM) questionnaire or equivalent symptom inventory. [20] Write a clinical note explicitly linking symptoms to biochemical findings. If the patient has tried and failed or cannot tolerate an alternative testosterone formulation, document that history.

Submit the PA through MaineCare's Gainwell portal or through the commercial plan's PA system with the lab results, clinical note, and diagnosis codes attached as supporting documentation. Follow up on the status within 48 hours if no response is received.

If the PA is denied, request a peer-to-peer review with the plan's medical director. Most Maine commercial plans allow prescribers to schedule a 15-minute call; denial reversal rates during peer-to-peer calls for testosterone products are substantially higher than written appeal rates based on general PA outcome data. [21]